Dual membrane receptor degradation via folate receptor targeting chimera.
Saved in:
| Title: | Dual membrane receptor degradation via folate receptor targeting chimera. |
|---|---|
| Authors: | Wang Z; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Li Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard University, Cambridge, MA, USA., Högström J; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Inuzuka H; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Jing R; Houston Methodist Cancer Center/Weill Cornell Medicine, Houston, TX, USA., Yan P; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Hou T; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Qi Y; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Huang D; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Wang J; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Wu T; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA., Shi X; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA., Liu B; Department of Interdisciplinary Oncology, Stanley S. Scott Cancer Center, LSU Health Sciences Center, New Orleans, LA, USA., Muranen T; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Zhang D; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. dzhang13@bidmc.harvard.edu., Wei W; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. wwei2@bidmc.harvard.edu. |
| Source: | Nature communications [Nat Commun] 2025 Oct 02; Vol. 16 (1), pp. 8804. Date of Electronic Publication: 2025 Oct 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41038820 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Dual membrane receptor degradation via folate receptor targeting chimera. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wang+Z%22">Wang Z</searchLink>; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Li+Z%22">Li Z</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard University, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Högström+J%22">Högström J</searchLink>; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Inuzuka+H%22">Inuzuka H</searchLink>; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Jing+R%22">Jing R</searchLink>; Houston Methodist Cancer Center/Weill Cornell Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Yan+P%22">Yan P</searchLink>; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hou+T%22">Hou T</searchLink>; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Qi+Y%22">Qi Y</searchLink>; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Huang+D%22">Huang D</searchLink>; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wu+T%22">Wu T</searchLink>; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shi+X%22">Shi X</searchLink>; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Liu+B%22">Liu B</searchLink>; Department of Interdisciplinary Oncology, Stanley S. Scott Cancer Center, LSU Health Sciences Center, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Muranen+T%22">Muranen T</searchLink>; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+D%22">Zhang D</searchLink>; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. dzhang13@bidmc.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Wei+W%22">Wei W</searchLink>; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. wwei2@bidmc.harvard.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2025 Oct 02; Vol. 16 (1), pp. 8804. <i>Date of Electronic Publication: </i>2025 Oct 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41038820 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-025-63882-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 8804 Titles: – TitleFull: Dual membrane receptor degradation via folate receptor targeting chimera. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wang Z – PersonEntity: Name: NameFull: Li Z – PersonEntity: Name: NameFull: Högström J – PersonEntity: Name: NameFull: Inuzuka H – PersonEntity: Name: NameFull: Jing R – PersonEntity: Name: NameFull: Yan P – PersonEntity: Name: NameFull: Hou T – PersonEntity: Name: NameFull: Qi Y – PersonEntity: Name: NameFull: Huang D – PersonEntity: Name: NameFull: Wang J – PersonEntity: Name: NameFull: Wu T – PersonEntity: Name: NameFull: Shi X – PersonEntity: Name: NameFull: Liu B – PersonEntity: Name: NameFull: Muranen T – PersonEntity: Name: NameFull: Zhang D – PersonEntity: Name: NameFull: Wei W IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 10 Text: 2025 Oct 02 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 16 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |